Brace yourselves, M&As are coming!

M&As happen all the time, but the intensity of their occurrence is cyclic, as is the global economy. M&A numbers and values always grow significantly after the economy has experienced severe shocks. Knowing that, it only seems rational to expect a wave of these transactions after the coronavirus turmoil is over.

Read more

Why do pharma companies need to tweak data integration?

Building competitiveness by optimizing processes, increasing efficiency, and making decisions based on data obviously makes sense, and is a global trend. But let’s not forget about the good old price competition, and with it — tool sets necessary to carry out pricing policies effectively in globally competitive markets.

Read more